Radio Advisory

Medical misinformation has been a significant problem for a long time, but amid the Covid-19 pandemic, the problem has become even more widespread. In this episode, host Rachel Woods sits down with Dr. Aaron Carroll, author, professor, and Indiana University chief health officer—to discuss what all clinicians should do to combat medical misinformation. Plus, Advisory Board experts Solomon Banjo and Pam Divack offer their take on clinician’s role in online spaces (with patients and with each other) and translate those same principles for the rest of the industry. Links: Online clinician communities Online Clinician Communities Cheat Sheet Healthcare Triage | YouTube Channel The Incidental Economist Aaron E. Carroll | The New York Times The Bad Food Bible: How and Why to Eat Sinfully Learn more: Innovation Showcase on Strategies to Advance Diversity (Submissions now closed) Equip your rising executives with the leadership and business skills they need to navigate the complexity of health care, solve difficult challenges and achieve breakthrough performance. Learn more about the Advisory Board Fellowship.

This podcast was recorded on September 16, 2021. The Covid-19 landscape is constantly shifting, including the status of vaccination, and it can all be a lot to keep track of. In this episode, host Rachel Woods sits down with Advisory Board's Pam Divack and Regina Lohr to talk about some of the questions regarding Covid-19 vaccines that still need to be answered—including mandates, outstanding approvals, dosing, and how to balance a national vs. global vaccination effort. On Friday September 17, FDA's Vaccines and Related Biological Products Advisory Committee recommended offering Pfizer booster shots for people ages 65 and older and for "high risk" individuals over the age of 16. It also voted against recommending boosters for all eligible adults, citing lack of more robust data on the younger age groups. This recommendation is not binding, and an official FDA decision is still to come. On Monday, September 20, Pfizer released new data showing lower doses of its Covid-19 vaccine are safe and shows 'robust' antibody response for 5- to 11-year-olds, without any serious safety issues. Pfizer expects to file for EUA soon, and experts say the shot may be authorized for kids by Halloween. Links: FDA panel recommends booster shots for some adults—but not all What Pfizer's clinical trial revealed about its Covid-19 vaccine in young children Are you ready for booster shots? Start thinking about these 6 factors now To retain staff, organizations need to invest in well-being beyond the workplace Learn more: Innovation Showcase on Strategies to Advance Diversity (submissions now closed)

Health care organizations have long been grappling with what their role is within their communities and how to approach health equity. In this episode, Rae sits down with Barry Ostrowsky, president and CEO of RWJBarnabas Health, to talk about the role of social justice in a health care organization and the specific steps that that he took to embed equity into every aspect of RWJBarnabas Health’s strategic plan. Links: Our latest research on health equity The health care CEO's guide to advancing health equity Equity Impact Assessment cheat sheet Learn more: Innovation Showcase on Strategies to Advance Diversity (submissions due before October 1)

The Covid-19 pandemic has led to massive digital investments in the health care industry. In this episode, host Rachel Woods sits down with Advisory Board's Ty Aderhold to talk about these investments, what their impact on equity could be, and why you might want to abandon the phrase "digital divide." Links: Stop talking about the 'digital divide' and start addressing 'digital inequity' Partnership, persistence, and patience: Key lessons from our panel on digital equity Digital inequity cheat sheet Digital literacy cheat sheet

Episode 38 was originally released on September 15, 2020. Addressing the social determinants of health (SDOH) within a community is a critical part of any population health strategy—and at ProMedica, it's a priority. In this episode, Rae speaks with ProMedica's Kate Sommerfeld, president of social determinants of health, and Brian Miller, chief medical information officer, about how their system addresses SDOH, what the business case is for tackling this issue, and why data and analytics are critical to focusing on SDOH. Links: For more information about ProMedica’s Social Determinants of Health efforts For more information about ProMedica's Social Determinants of Health solutions for employers Social Determinants of Health Data The field guide for defining providers' role in addressing social determinants of health Here's how 4 organizations are leveraging IT to address social determinants of health

Episode 61 was originally released on March 2, 2021. The Covid-19 epidemic has put a nearly inconceivable amount of stress on the health care workforce over the past year, so how do health care leaders help develop a culture of resilience among their staff? In this episode, Rae sits down with Advisory Board's Katherine Virkstis and Anne Herleth to talk about what resilience actually means and how providers should change their approach to resilience amid the Covid-19 epidemic. At the end of this episode, Rae asks leadership expert Craig Pirner to go deeper on the role all leaders should play in enabling a culture of resilience. Links: Three strategies to build baseline emotional support How to provide emotional supports for your workforce Picklist of emotional support options Cracks in the Foundation of the Care Environment Undermine Nurse Resilience | JONA: Journal of Nursing Administration

Episode 69 was originally released on April 27, 2021. The Covid-19 epidemic has led to a rapid expansion in the digital health space, but how many of those innovations will stick around after the epidemic is over? In this episode, Rae sits down with Warner Thomas, president and CEO of Ochsner Health, to talk about the future of digital health and how Ochsner has been investing in the space. Plus, strategy expert Colin Gelbaugh recaps what we’ve learned about volumes in the first quarter of 2021 and offers his predictions for what’s to come for the rest of the year. Links: Ochsner Digital Medicine innovationOchsner (iO) 7 worthwhile digital front door investments

Episode 78 was originally released on June 8, 2021. The Covid-19 pandemic has shaken the health care industry over the past year, but what can health systems and health plans expect financially going forward? In this episode, Rae sits down with Advisory Board's Natalie Trebes and Christopher Kerns to talk about the financial outlook for health systems and health plans for the rest of 2021 and beyond. Links: Provider financial outlook: Continued volume recovery—but modest gains in margins and huge variability across the board Radio Advisory Playlist: Financial Impact episodes

The Covid-19 pandemic has exacerbated an already-bad behavioral health crisis in the United States, which has led the health care industry to invest heavily in virtual telehealth—an investment that could do a lot a good, but isn't without its risks. In this episode, Rae sits down with Advisory Board's Nick Cericola and Clare Wirth to talk about the potential consequences that could come with the health industry's recent investment in virtual behavioral health. Links: Investors are pouring money into virtual behavioral health companies—good news for many patients, but not without risks A year into the pandemic, here’s how behavioral health care is changing—for the worse and for the better Ep. 23: How behavioral health in the US is affected by Covid-19 Radio Advisory Playlist: Behavioral health episodes

Last week, CMS released its proposed payment rule for hospital outpatient departments and ambulatory surgery centers for 2022. In this episode, Rae sits down with Advisory Board's Heather Bell and Rob Lazerow to dive into the proposed rule and discuss what it means for hospitals, specifically in the realm of price transparency and site of care shifts. Links: The IPO list is here to stay—and 3 other surprises in CMS' 2022 outpatient proposed rule How will CMS' removal of the IPO list affect your hospital? Here's how to find out. Ep. 76: Transparency and surprise billing: The biggest policies coming your way